調査レポート | • レポートコード：QYR2104Z2475 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ガリデシビルのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ガリデシビル粉末、ガリデシビル塩酸塩）、用途別市場規模（マールブルグウイルス病、フィロウイルス感染症/エボラウイルス感染症、黄熱病）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ガリデシビルの市場動向 ・企業の競争状況、市場シェア ・ガリデシビルの種類別市場規模（ガリデシビル粉末、ガリデシビル塩酸塩） ・ガリデシビルの用途別市場規模（マールブルグウイルス病、フィロウイルス感染症/エボラウイルス感染症、黄熱病） ・ガリデシビルの北米市場規模2016-2027（アメリカ、カナダ） ・ガリデシビルのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ガリデシビルのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ガリデシビルの中南米市場規模2016-2027（メキシコ、ブラジル） ・ガリデシビルの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（BioCryst Pharmaceuticals、ChemScene、Taiclone、CliniSciences、Xi'an Henrikang Biotech Co.、Cayman Chemical） ・結論 |
Galidesivir is an adenosine analogue that has been investigated for use against Zaire Ebolavirus. In animal studies, galidesivir was effective in increasing the survival rates from infections caused by various pathogens, including Ebola, Marburg, Yellow Fever and Zika viruses. Phase 1 clinical trials have begun to determine the safety of this drug in humans. Because of its activity against other coronaviruses, it may be studied as a potential therapy for COVID-19.
Market Analysis and Insights: Global Galidesivir Market
The global Galidesivir market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Galidesivir market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Galidesivir market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Galidesivir market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Galidesivir market.
Global Galidesivir Scope and Market Size
Galidesivir market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Galidesivir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Galidesivir Powder
Galidesivir Hydrochloride
Segment by Application
Marburg Virus Disease
Filovirus Infections/Ebola Virus Infection
Yellow Fever
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
BioCryst Pharmaceuticals
ChemScene
Taiclone
CliniSciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Galidesivir Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Galidesivir Powder
1.2.3 Galidesivir Hydrochloride
1.3 Market by Application
1.3.1 Global Galidesivir Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Marburg Virus Disease
1.3.3 Filovirus Infections/Ebola Virus Infection
1.3.4 Yellow Fever
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Galidesivir Market Perspective (2016-2027)
2.2 Galidesivir Growth Trends by Regions
2.2.1 Galidesivir Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Galidesivir Historic Market Share by Regions (2016-2021)
2.2.3 Galidesivir Forecasted Market Size by Regions (2022-2027)
2.3 Galidesivir Industry Dynamic
2.3.1 Galidesivir Market Trends
2.3.2 Galidesivir Market Drivers
2.3.3 Galidesivir Market Challenges
2.3.4 Galidesivir Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Galidesivir Players by Revenue
3.1.1 Global Top Galidesivir Players by Revenue (2016-2021)
3.1.2 Global Galidesivir Revenue Market Share by Players (2016-2021)
3.2 Global Galidesivir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Galidesivir Revenue
3.4 Global Galidesivir Market Concentration Ratio
3.4.1 Global Galidesivir Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Galidesivir Revenue in 2020
3.5 Galidesivir Key Players Head office and Area Served
3.6 Key Players Galidesivir Product Solution and Service
3.7 Date of Enter into Galidesivir Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Galidesivir Breakdown Data by Type
4.1 Global Galidesivir Historic Market Size by Type (2016-2021)
4.2 Global Galidesivir Forecasted Market Size by Type (2022-2027)
5 Galidesivir Breakdown Data by Application
5.1 Global Galidesivir Historic Market Size by Application (2016-2021)
5.2 Global Galidesivir Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Galidesivir Market Size (2016-2027)
6.2 North America Galidesivir Market Size by Type
6.2.1 North America Galidesivir Market Size by Type (2016-2021)
6.2.2 North America Galidesivir Market Size by Type (2022-2027)
6.2.3 North America Galidesivir Market Size by Type (2016-2027)
6.3 North America Galidesivir Market Size by Application
6.3.1 North America Galidesivir Market Size by Application (2016-2021)
6.3.2 North America Galidesivir Market Size by Application (2022-2027)
6.3.3 North America Galidesivir Market Size by Application (2016-2027)
6.4 North America Galidesivir Market Size by Country
6.4.1 North America Galidesivir Market Size by Country (2016-2021)
6.4.2 North America Galidesivir Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Galidesivir Market Size (2016-2027)
7.2 Europe Galidesivir Market Size by Type
7.2.1 Europe Galidesivir Market Size by Type (2016-2021)
7.2.2 Europe Galidesivir Market Size by Type (2022-2027)
7.2.3 Europe Galidesivir Market Size by Type (2016-2027)
7.3 Europe Galidesivir Market Size by Application
7.3.1 Europe Galidesivir Market Size by Application (2016-2021)
7.3.2 Europe Galidesivir Market Size by Application (2022-2027)
7.3.3 Europe Galidesivir Market Size by Application (2016-2027)
7.4 Europe Galidesivir Market Size by Country
7.4.1 Europe Galidesivir Market Size by Country (2016-2021)
7.4.2 Europe Galidesivir Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Galidesivir Market Size (2016-2027)
8.2 Asia-Pacific Galidesivir Market Size by Type
8.2.1 Asia-Pacific Galidesivir Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Galidesivir Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Galidesivir Market Size by Type (2016-2027)
8.3 Asia-Pacific Galidesivir Market Size by Application
8.3.1 Asia-Pacific Galidesivir Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Galidesivir Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Galidesivir Market Size by Application (2016-2027)
8.4 Asia-Pacific Galidesivir Market Size by Region
8.4.1 Asia-Pacific Galidesivir Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Galidesivir Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Galidesivir Market Size (2016-2027)
9.2 Latin America Galidesivir Market Size by Type
9.2.1 Latin America Galidesivir Market Size by Type (2016-2021)
9.2.2 Latin America Galidesivir Market Size by Type (2022-2027)
9.2.3 Latin America Galidesivir Market Size by Type (2016-2027)
9.3 Latin America Galidesivir Market Size by Application
9.3.1 Latin America Galidesivir Market Size by Application (2016-2021)
9.3.2 Latin America Galidesivir Market Size by Application (2022-2027)
9.3.3 Latin America Galidesivir Market Size by Application (2016-2027)
9.4 Latin America Galidesivir Market Size by Country
9.4.1 Latin America Galidesivir Market Size by Country (2016-2021)
9.4.2 Latin America Galidesivir Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Galidesivir Market Size (2016-2027)
10.2 Middle East & Africa Galidesivir Market Size by Type
10.2.1 Middle East & Africa Galidesivir Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Galidesivir Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Galidesivir Market Size by Type (2016-2027)
10.3 Middle East & Africa Galidesivir Market Size by Application
10.3.1 Middle East & Africa Galidesivir Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Galidesivir Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Galidesivir Market Size by Application (2016-2027)
10.4 Middle East & Africa Galidesivir Market Size by Country
10.4.1 Middle East & Africa Galidesivir Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Galidesivir Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BioCryst Pharmaceuticals
11.1.1 BioCryst Pharmaceuticals Company Details
11.1.2 BioCryst Pharmaceuticals Business Overview
11.1.3 BioCryst Pharmaceuticals Galidesivir Introduction
11.1.4 BioCryst Pharmaceuticals Revenue in Galidesivir Business (2016-2021)
11.1.5 BioCryst Pharmaceuticals Recent Development
11.2 ChemScene
11.2.1 ChemScene Company Details
11.2.2 ChemScene Business Overview
11.2.3 ChemScene Galidesivir Introduction
11.2.4 ChemScene Revenue in Galidesivir Business (2016-2021)
11.2.5 ChemScene Recent Development
11.3 Taiclone
11.3.1 Taiclone Company Details
11.3.2 Taiclone Business Overview
11.3.3 Taiclone Galidesivir Introduction
11.3.4 Taiclone Revenue in Galidesivir Business (2016-2021)
11.3.5 Taiclone Recent Development
11.4 CliniSciences
11.4.1 CliniSciences Company Details
11.4.2 CliniSciences Business Overview
11.4.3 CliniSciences Galidesivir Introduction
11.4.4 CliniSciences Revenue in Galidesivir Business (2016-2021)
11.4.5 CliniSciences Recent Development
11.5 Xi’an Henrikang Biotech Co.
11.5.1 Xi’an Henrikang Biotech Co. Company Details
11.5.2 Xi’an Henrikang Biotech Co. Business Overview
11.5.3 Xi’an Henrikang Biotech Co. Galidesivir Introduction
11.5.4 Xi’an Henrikang Biotech Co. Revenue in Galidesivir Business (2016-2021)
11.5.5 Xi’an Henrikang Biotech Co. Recent Development
11.6 Cayman Chemical
11.6.1 Cayman Chemical Company Details
11.6.2 Cayman Chemical Business Overview
11.6.3 Cayman Chemical Galidesivir Introduction
11.6.4 Cayman Chemical Revenue in Galidesivir Business (2016-2021)
11.6.5 Cayman Chemical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Galidesivir Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Galidesivir Powder
Table 3. Key Players of Galidesivir Hydrochloride
Table 4. Global Galidesivir Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Galidesivir Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Galidesivir Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Galidesivir Market Share by Regions (2016-2021)
Table 8. Global Galidesivir Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Galidesivir Market Share by Regions (2022-2027)
Table 10. Galidesivir Market Trends
Table 11. Galidesivir Market Drivers
Table 12. Galidesivir Market Challenges
Table 13. Galidesivir Market Restraints
Table 14. Global Galidesivir Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Galidesivir Market Share by Players (2016-2021)
Table 16. Global Top Galidesivir Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Galidesivir as of 2020)
Table 17. Ranking of Global Top Galidesivir Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Galidesivir Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Galidesivir Product Solution and Service
Table 21. Date of Enter into Galidesivir Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Galidesivir Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Galidesivir Revenue Market Share by Type (2016-2021)
Table 25. Global Galidesivir Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Galidesivir Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Galidesivir Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Galidesivir Revenue Market Share by Application (2016-2021)
Table 29. Global Galidesivir Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Galidesivir Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Galidesivir Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Galidesivir Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Galidesivir Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Galidesivir Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Galidesivir Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Galidesivir Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Galidesivir Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Galidesivir Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Galidesivir Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Galidesivir Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Galidesivir Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Galidesivir Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Galidesivir Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Galidesivir Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Galidesivir Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Galidesivir Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Galidesivir Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Galidesivir Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Galidesivir Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Galidesivir Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Galidesivir Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Galidesivir Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Galidesivir Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Galidesivir Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Galidesivir Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Galidesivir Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Galidesivir Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Galidesivir Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Galidesivir Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Galidesivir Market Size by Country (2022-2027) & (US$ Million)
Table 61. BioCryst Pharmaceuticals Company Details
Table 62. BioCryst Pharmaceuticals Business Overview
Table 63. BioCryst Pharmaceuticals Galidesivir Product
Table 64. BioCryst Pharmaceuticals Revenue in Galidesivir Business (2016-2021) & (US$ Million)
Table 65. BioCryst Pharmaceuticals Recent Development
Table 66. ChemScene Company Details
Table 67. ChemScene Business Overview
Table 68. ChemScene Galidesivir Product
Table 69. ChemScene Revenue in Galidesivir Business (2016-2021) & (US$ Million)
Table 70. ChemScene Recent Development
Table 71. Taiclone Company Details
Table 72. Taiclone Business Overview
Table 73. Taiclone Galidesivir Product
Table 74. Taiclone Revenue in Galidesivir Business (2016-2021) & (US$ Million)
Table 75. Taiclone Recent Development
Table 76. CliniSciences Company Details
Table 77. CliniSciences Business Overview
Table 78. CliniSciences Galidesivir Product
Table 79. CliniSciences Revenue in Galidesivir Business (2016-2021) & (US$ Million)
Table 80. CliniSciences Recent Development
Table 81. Xi'an Henrikang Biotech Co. Company Details
Table 82. Xi'an Henrikang Biotech Co. Business Overview
Table 83. Xi'an Henrikang Biotech Co. Galidesivir Product
Table 84. Xi'an Henrikang Biotech Co. Revenue in Galidesivir Business (2016-2021) & (US$ Million)
Table 85. Xi'an Henrikang Biotech Co. Recent Development
Table 86. Cayman Chemical Company Details
Table 87. Cayman Chemical Business Overview
Table 88. Cayman Chemical Galidesivir Product
Table 89. Cayman Chemical Revenue in Galidesivir Business (2016-2021) & (US$ Million)
Table 90. Cayman Chemical Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Galidesivir Market Share by Type: 2020 VS 2027
Figure 2. Galidesivir Powder Features
Figure 3. Galidesivir Hydrochloride Features
Figure 4. Global Galidesivir Market Share by Application: 2020 VS 2027
Figure 5. Marburg Virus Disease Case Studies
Figure 6. Filovirus Infections/Ebola Virus Infection Case Studies
Figure 7. Yellow Fever Case Studies
Figure 8. Galidesivir Report Years Considered
Figure 9. Global Galidesivir Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Galidesivir Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Galidesivir Market Share by Regions: 2020 VS 2027
Figure 12. Global Galidesivir Market Share by Regions (2022-2027)
Figure 13. Global Galidesivir Market Share by Players in 2020
Figure 14. Global Top Galidesivir Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Galidesivir as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Galidesivir Revenue in 2020
Figure 16. Global Galidesivir Revenue Market Share by Type (2016-2021)
Figure 17. Global Galidesivir Revenue Market Share by Type (2022-2027)
Figure 18. North America Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Galidesivir Market Share by Type (2016-2027)
Figure 20. North America Galidesivir Market Share by Application (2016-2027)
Figure 21. North America Galidesivir Market Share by Country (2016-2027)
Figure 22. United States Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Galidesivir Market Share by Type (2016-2027)
Figure 26. Europe Galidesivir Market Share by Application (2016-2027)
Figure 27. Europe Galidesivir Market Share by Country (2016-2027)
Figure 28. Germany Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Galidesivir Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Galidesivir Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Galidesivir Market Share by Region (2016-2027)
Figure 38. China Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Galidesivir Market Share by Type (2016-2027)
Figure 46. Latin America Galidesivir Market Share by Application (2016-2027)
Figure 47. Latin America Galidesivir Market Share by Country (2016-2027)
Figure 48. Mexico Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Galidesivir Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Galidesivir Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Galidesivir Market Share by Country (2016-2027)
Figure 54. Turkey Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Galidesivir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. BioCryst Pharmaceuticals Revenue Growth Rate in Galidesivir Business (2016-2021)
Figure 58. ChemScene Revenue Growth Rate in Galidesivir Business (2016-2021)
Figure 59. Taiclone Revenue Growth Rate in Galidesivir Business (2016-2021)
Figure 60. CliniSciences Revenue Growth Rate in Galidesivir Business (2016-2021)
Figure 61. Xi'an Henrikang Biotech Co. Revenue Growth Rate in Galidesivir Business (2016-2021)
Figure 62. Cayman Chemical Revenue Growth Rate in Galidesivir Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の呼吸器ウイルス感染症治療薬市場規模・現状・予測（2021年-2027年） North America dominated the global respiratory virus infection drugs market in 2019. The trend is anticipated to continue during the forecast period. Strategies adopted by key players, such as product approvals & launch and mergers & acquisitions, well-established healthcare infrastructure, and earl…- 世界の単純ヘルペスウイルス感染症治療市場規模・現状・予測（2021年-2027年） Herpes Simplex Virus Infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blis…
- 世界のデング熱ウイルス診断検査市場規模・現状・予測（2021年-2027年） Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrom…
- 世界のデング熱ウイルス診断検査市場規模・現状・予測（2021年-2027年） Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrom…
- 世界のB型肝炎ウイルス（HBV）市場規模・現状・予測（2021年-2027年） Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…